Clavulanic acid potassium salt (Potassium Clavulanate)/Avicel (1:1) CAS:61177-45-5

Potassium clavulanate is commonly used in combination with antibiotics to treat a variety of bacterial infections. By inhibiting beta-lactamase enzymes produced by some bacteria, potassium clavulanate helps to extend the spectrum of activity of antibiotics like amoxicillin, allowing them to effectively combat a broader range of bacterial strains. This combination therapy is frequently employed in respiratory tract infections, urinary tract infections, skin and soft tissue infections, and dental infections where the presence of beta-lactamase-producing bacteria may compromise antibiotic efficacy. The addition of potassium clavulanate helps overcome bacterial resistance mechanisms, enhancing treatment outcomes. Patients should follow the prescribed dosage and regimen provided by healthcare professionals when taking medications containing potassium clavulanate. Completing the full course of treatment is essential to ensure the eradication of the infecting bacteria and to reduce the risk of recurrent infections or antibiotic resistance development. While generally well-tolerated, side effects such as gastrointestinal upset or allergic reactions may occur. Patients should consult their healthcare provider if they experience severe symptoms or adverse effects during treatment. When used appropriately in conjunction with antibiotics, potassium clavulanate plays a crucial role in combating bacterial infections effectively.